668 related articles for article (PubMed ID: 10796715)
1. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
[TBL] [Abstract][Full Text] [Related]
3. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
Furness S; Roberts H; Marjoribanks J; Lethaby A; Hickey M; Farquhar C
Cochrane Database Syst Rev; 2009 Apr; (2):CD000402. PubMed ID: 19370558
[TBL] [Abstract][Full Text] [Related]
4. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
Furness S; Roberts H; Marjoribanks J; Lethaby A
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD000402. PubMed ID: 22895916
[TBL] [Abstract][Full Text] [Related]
5. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
6. Cyclical progestogens for heavy menstrual bleeding.
Lethaby A; Irvine G; Cameron I
Cochrane Database Syst Rev; 2000; (2):CD001016. PubMed ID: 10796587
[TBL] [Abstract][Full Text] [Related]
7. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Romero SA; Young K; Hickey M; Su HI
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
Tan YH; Lethaby A
Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Mittermeier T; Farrant C; Wise MR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
[TBL] [Abstract][Full Text] [Related]
10. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
Aylward M; Maddock J; Parker A; Protheroe DA; Ward A
Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584
[TBL] [Abstract][Full Text] [Related]
11. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Dominick S; Hickey M; Chin J; Su HI
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
[TBL] [Abstract][Full Text] [Related]
12. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation.
Hickey M; Higham J; Fraser IS
Cochrane Database Syst Rev; 2007 Oct; (4):CD001895. PubMed ID: 17943761
[TBL] [Abstract][Full Text] [Related]
13. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
Naheed B; Kuiper JH; Uthman OA; O'Mahony F; O'Brien PM
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010503. PubMed ID: 28257559
[TBL] [Abstract][Full Text] [Related]
14. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
[TBL] [Abstract][Full Text] [Related]
15. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
[TBL] [Abstract][Full Text] [Related]
16. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
[TBL] [Abstract][Full Text] [Related]
17. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation.
Hickey M; Higham J; Fraser IS
Cochrane Database Syst Rev; 2000; (2):CD001895. PubMed ID: 10796833
[TBL] [Abstract][Full Text] [Related]
18. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
[TBL] [Abstract][Full Text] [Related]
19. Cyclical progestogens for heavy menstrual bleeding.
Lethaby A; Irvine G; Cameron I
Cochrane Database Syst Rev; 2008 Jan; (1):CD001016. PubMed ID: 18253983
[TBL] [Abstract][Full Text] [Related]
20. Cyclical progestogens for heavy menstrual bleeding.
Bofill Rodriguez M; Lethaby A; Low C; Cameron IT
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD001016. PubMed ID: 31425626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]